Filing Details
- Accession Number:
- 0001209191-13-013991
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-03-05 16:42:18
- Reporting Period:
- 2013-02-28
- Filing Date:
- 2013-03-05
- Accepted Time:
- 2013-03-05 16:42:18
- Original Submission Date:
- 2013-03-04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
868368 | Rochester Medical Corporation | ROCM | Surgical & Medical Instruments & Apparatus (3841) | 411613227 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1211656 | R Martyn Sholtis | One Rochester Medical Drive Stewartville MN 55976 | Corporate Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-02-28 | 1,500 | $14.80 | 40,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-03-01 | 12,000 | $4.63 | 52,000 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-03-01 | 3,000 | $4.70 | 55,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-03-01 | 15,000 | $14.75 | 40,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-03-01 | 12,000 | $0.00 | 12,000 | $4.63 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-03-01 | 3,000 | $0.00 | 30,000 | $4.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-01-02 | 2014-01-02 | No | 4 | M | Direct |
27,000 | 2006-01-01 | 2015-01-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 41,500 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $5.70 | 2007-01-26 | 2016-01-26 | 20,000 | 20,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $12.30 | 2007-11-21 | 2016-11-21 | 20,000 | 20,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $11.23 | 2009-02-06 | 2018-02-06 | 20,000 | 20,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $11.27 | 2010-02-03 | 2019-02-03 | 20,000 | 20,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $12.27 | 2011-01-28 | 2020-01-28 | 20,000 | 20,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $10.72 | 2012-01-27 | 2021-01-27 | 20,000 | 20,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2016-01-26 | 20,000 | 20,000 | Direct |
2016-11-21 | 20,000 | 20,000 | Direct |
2018-02-06 | 20,000 | 20,000 | Direct |
2019-02-03 | 20,000 | 20,000 | Direct |
2020-01-28 | 20,000 | 20,000 | Direct |
2021-01-27 | 20,000 | 20,000 | Direct |
Footnotes
- Includes restricted stock award shares.
- The amount of shares held has been adjusted to reflect an increase of 1,500 shares reported on a Form 4 reporting a 2011 purchase filed concurrently with this amendment. These shares were also omitted from one interim Form 4 filed in December 2012.
- The price in Column 4 is a weighted average. The prices actually received ranged from $14.79 to $14.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Amends incorrect share and option amounts reported on a Form 4 filed March 4, 2013. Total options exercised were 15,000 not 16,500 as reported on prior filing.
- Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown.